SASH1 has been shown to be downregulated in many cancers.6 These data are highly significant for cancer treatment as they suggest that cancer cells with low SASH1 levels might be more resistant to DNA damage-induced apoptosis than cancer cells with higher levels of SASH1. This evidence concerns the gene SASH1 and cancer.